Insider trading

Period: 120 months Stock: DYN + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

293 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

293 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

293 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

293 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
293 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
293 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

293 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
16 Apr 2026
Kersten Dirk Director · indirect
Sold on a plan 2×
$368.11K 17,773 at 20.71
0.4%
Planned (10b5-1)
15 Apr 2026
Kersten Dirk Director · indirect
Sold on a plan
$1.66M 81,840 at 20.27
1.8%
Planned (10b5-1)
1 Apr 2026
Lucera Erick Chief Financial Officer
Sold on a plan
$106.75K 5,727 at 18.64
4.4%
Planned (10b5-1)
30 Mar 2026
Posner Brian S Director
Bought
$34.16K 2,000 at 17.08
14.8%
11 Mar 2026
Kersten Dirk Director · indirect
Sold on a plan
$2.53M 129,672 at 19.52
2.7%
Planned (10b5-1)
11 Mar 2026
Posner Brian S Director
Bought
$38.70K 2,000 at 19.35
17.4%
10 Mar 2026
Kersten Dirk Director · indirect
Sold on a plan 3×
$10.00M 511,098 at 19.57
9.7%
Planned (10b5-1)
9 Mar 2026
Kersten Dirk Director · indirect
Sold on a plan
$3.15M 177,690 at 17.72
3.3%
Planned (10b5-1)
6 Mar 2026
Posner Brian S Director
Bought
$45.18K 3,000 at 15.06
35.3%
First buy on file
5 Mar 2026
Cox John CEO & President
Sold on a plan
$40.71K 2,732 at 14.90
0.7%
Planned (10b5-1)
5 Mar 2026
Kerr Douglas Chief Medical Officer
Sold on a plan
$13.47K 904 at 14.90
0.5%
Planned (10b5-1)
5 Mar 2026
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$2.21K 148 at 14.90
0.1%
Planned (10b5-1)
5 Dec 2025
Cox John CEO & President
Sold on a plan
$55.16K 2,662 at 20.72
1.3%
Planned (10b5-1)
5 Dec 2025
Kerr Douglas Chief Medical Officer
Sold on a plan
$18.23K 880 at 20.72
1.0%
Planned (10b5-1)
5 Dec 2025
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$2.98K 144 at 20.72
0.2%
Planned (10b5-1)
5 Sep 2025
Cox John CEO & President
Sold on a plan
$35.40K 2,640 at 13.41
1.3%
Planned (10b5-1)
5 Sep 2025
Kerr Douglas Chief Medical Officer
Sold on a plan
$11.71K 873 at 13.41
1.0%
Planned (10b5-1)
5 Sep 2025
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$1.93K 144 at 13.41
0.2%
Planned (10b5-1)
4 Sep 2025
Kerr Douglas Chief Medical Officer
Sold on a plan
$47.14K 3,552 at 13.27
3.8%
Planned (10b5-1)
4 Sep 2025
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$11.86K 894 at 13.27
0.9%
Planned (10b5-1)
14 Jul 2025
Cox John CEO & President
Bought
$911.00K 100,000 at 9.11
70.3%
+70% of stake
5 Jun 2025
Cox John CEO & President
Sold on a plan
$54.20K 4,060 at 13.35
2.8%
Planned (10b5-1)
5 Jun 2025
Kerr Douglas Chief Medical Officer
Sold on a plan
$17.92K 1,342 at 13.35
1.4%
Planned (10b5-1)
5 Jun 2025
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$1.95K 146 at 13.35
0.2%
Planned (10b5-1)
13 Mar 2025
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$1.73K 143 at 12.12
0.1%
Planned (10b5-1)
11 Mar 2025
Beskrovnaya Oxana Chief Scientific Officer
Sold on a plan
$24.50K 2,153 at 11.38
1.1%
Planned (10b5-1)
11 Mar 2025
Scalzo Richard William SVP, Head of Finance & Admin.
Sold on a plan
$15.28K 1,343 at 11.38
1.1%
Planned (10b5-1)
5 Mar 2025
Cox John CEO & President
Sold on a plan
$48.04K 4,061 at 11.83
2.7%
Planned (10b5-1)
5 Mar 2025
Kerr Douglas Chief Medical Officer
Sold on a plan
$15.89K 1,343 at 11.83
1.4%
Planned (10b5-1)
5 Mar 2025
Beskrovnaya Oxana Chief Scientific Officer
Sold on a plan
$12.94K 1,094 at 11.83
0.5%
Planned (10b5-1)
5 Mar 2025
Scalzo Richard William SVP, Head of Finance & Admin.
Sold on a plan
$10.85K 917 at 11.83
0.7%
Planned (10b5-1)
18 Feb 2025
Beskrovnaya Oxana Chief Scientific Officer
Sold on a plan
$36.24K 2,598 at 13.95
1.3%
Planned (10b5-1)
18 Feb 2025
Scalzo Richard William SVP, Head of Finance & Admin.
Sold on a plan
$34.71K 2,488 at 13.95
2.0%
Planned (10b5-1)
11 Dec 2024
Beskrovnaya Oxana Chief Scientific Officer
Sold on a plan
$65.63K 2,334 at 28.12
1.1%
Planned (10b5-1)
11 Dec 2024
Scalzo Richard William SVP, Head of Finance & Admin.
Sold on a plan
$40.91K 1,455 at 28.12
1.1%
Planned (10b5-1)
9 Dec 2024
Kersten Dirk Director · indirect
Sold at will
$1.00M 34,437 at 29.18
0.6%
Not planned
6 Dec 2024
Kersten Dirk Director · indirect
Sold at will
$2.98M 101,675 at 29.34
1.8%
Not planned
5 Dec 2024
Kersten Dirk Director · indirect
Sold at will
$110.56K 3,806 at 29.05
0.1%
Not planned
4 Dec 2024
Kersten Dirk Director · indirect
Sold at will
$3.97M 135,039 at 29.39
2.4%
Not planned
3 Dec 2024
Kersten Dirk Director · indirect
Sold at will
$863.71K 29,732 at 29.05
0.5%
Not planned
2 Dec 2024
Kersten Dirk Director · indirect
Sold at will 2×
$2.41M 81,201 at 29.67
1.4%
Not planned
18 Nov 2024
Incerti Carlo Director
Sold at will
$474.05K 16,500 at 28.73
100%
Sold half or more
18 Nov 2024
Beskrovnaya Oxana Chief Scientific Officer
Sold on a plan
$80.54K 2,856 at 28.20
2.0%
Planned (10b5-1)
18 Nov 2024
Scalzo Richard William SVP, Head of Finance & Admin.
Sold on a plan
$77.13K 2,735 at 28.20
2.8%
Planned (10b5-1)
14 Nov 2024
Kersten Dirk Director · indirect
Sold on a plan
$293.05K 8,929 at 32.82
0.2%
Planned (10b5-1)
14 Nov 2024
Rhodes Jason P Director · indirect
Sold at will 4×
$25.88K 782 at 33.10
4.7%
Not planned
13 Nov 2024
Kersten Dirk Director · indirect
Sold on a plan
$380.70K 10,803 at 35.24
14.8%
Planned (10b5-1)
21 Oct 2024
Kersten Dirk Director · indirect
Sold on a plan
$4.24K 121 at 35.06
0.2%
Planned (10b5-1)
18 Oct 2024
Kersten Dirk Director · indirect
Sold on a plan
$471.64K 13,414 at 35.16
15.5%
Planned (10b5-1)
17 Oct 2024
Kersten Dirk Director · indirect
Sold on a plan
$457.67K 13,013 at 35.17
13.1%
Planned (10b5-1)
Showing 51–100 of 293. ← Newer Page 2 of 6 Older →